Rybelsus 7 mg Semaglutide Tablets
Rybelsus 7 mg is an oral prescription medication designed to help manage blood sugar levels in adults with type 2 diabetes. Developed and manufactured by Novo Nordisk, Rybelsus contains the active ingredient semaglutide, an effective GLP-1 receptor agonist.Mechanism of ActionSemaglutide mimics the action of natural incretin hormones in the body. It stimulates glucose-dependent insulin secretion fr
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Rybelsus 7 mg is an oral prescription medication designed to help manage blood sugar levels in adults with type 2 diabetes. Developed and manufactured by Novo Nordisk, Rybelsus contains the active ingredient semaglutide, an effective GLP-1 receptor agonist.
Mechanism of Action
Semaglutide mimics the action of natural incretin hormones in the body. It stimulates glucose-dependent insulin secretion from pancreatic beta cells while suppressing unnecessary glucagon production by the liver, contributing to stabilized blood glucose and reduced postprandial spikes.
Key Benefits
- Blood Sugar Regulation: Assists in lowering and maintaining glycemic control and reducing A1c levels.
- Cardiovascular Support: Helps reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes.
- Weight Management Support: Aids in weight management as a secondary benefit alongside proper diet and exercise.
- Oral Form Factor: Offers an oral tablet alternative within the GLP-1 receptor agonist class.
| Brand | Rybelsus |
| Manufacturer | Novo Nordisk |
| Active Ingredient | Semaglutide |
| Dosage Strength | 7 mg |
| Drug Class | Glucagon-like peptide-1 (GLP-1) |
| Primary Indication | Type 2 Diabetes |
| Dosage Form | Tablet |
| Packaging Format | 10 Tablets in 1 strip |
| Brand | Rybelsus |
|---|








Reviews
There are no reviews yet.